Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone

被引：0
|
作者：
Kuley, Brandon [1 ]
Storey, Philip [2 ]
Pancholy, Maitri [1 ]
Obeid, Anthony [2 ]
Murphy, James [1 ]
Goodman, Jake [1 ]
Wibbelsman, Turner D. [2 ]
Regillo, Carl [2 ]
Chiang, Allen [2 ]
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
[2] Wills Eye Hosp & Res Inst, Retina, Philadelphia, PA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2645
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Trabecular microbypass stent to treat ocular hypertension after intravitreal injection of a dexamethasone implant
    Guemes-Villahoz, N.
    Garcia-Feijoo, J.
    Martinez-de-la-Casa, J. M.
    Torres-Imaz, R.
    Donate-Lopez, J.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (10): : E591 - E594
  • [22] Ocular Complications After Dexamethasone Implant Versus Intravitreal Triamcinolone in Patients with Post Vitrectomy Macular Edema
    Anderson, Hannah
    Liu, Catherine Kai-Ray
    Wakabayashi, Taku
    Mahmoudzadeh, Raziyeh
    Salabati, Mirataollah
    Spirn, Marc
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [23] Treatment of Eyes With Diabetic Macular Edema That Had a Suboptimal Response to Antivascular Endothelial Growth Factor Therapy: 2-mg Intravitreal Triamcinolone Acetonide vs 0.7-mg Dexamethasone Implant
    Kuley, Brandon
    Storey, Philip P.
    Pancholy, Maitri
    Wibbelsman, Turner D.
    Obeid, Anthony
    Regillo, Carl
    Garg, Sunir
    JOURNAL OF VITREORETINAL DISEASES, 2020, 4 (05) : 372 - 376
  • [24] Effect of Intravitreal Injection of Dexamethasone 0.7 mg (Ozurdex®) on Intraocular Pressure in Patients with Macular Edema
    Mazzarella, Stefania
    Mateo, Carlos
    Freixes, Silvia
    Bures-Jelstrup, Anniken
    Rios, Jose
    Navarro, Rafael
    Garcia-Arumi, Jose
    Corcostegui, Borja
    Arrondo, Elena
    OPHTHALMIC RESEARCH, 2015, 54 (03) : 143 - 149
  • [25] Retrospective Study of Two or More Dexamethasone Intravitreal Implant 0.7 mg Injections for Retinal Vein Occlusion
    Capone, Antonio
    Singer, Michael
    Dodwell, David
    Dreyer, Richard
    Oh, Kean
    Roth, Daniel
    Walt, John
    Scott, Lanita
    Hollander, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [26] Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant
    Landre, C.
    Zourdani, A.
    Gastaud, P.
    Baillif, S.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2016, 39 (01): : 5 - 11
  • [27] Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
    Lam, Wai-Ching
    Albiani, David A.
    Yoganathan, Pradeepa
    Chen, John Chanchiang
    Kherani, Amin
    Maberley, David A. L.
    Oliver, Alejandro
    Rabinovitch, Theodore
    Sheidow, Thomas G.
    Tourville, Eric
    Wittenberg, Leah A.
    Sigouin, Chris
    Baptiste, Darryl C.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 1255 - 1268
  • [28] Cystoid Macular Edema after Complicated Cataract Surgery Resolved by an Intravitreal Dexamethasone 0.7-mg Implant
    Meyer, Linda M.
    Schoenfeld, Carl-Ludwig
    CASE REPORTS IN OPHTHALMOLOGY, 2011, 2 (03): : 319 - 322
  • [29] Sustained ocular hypertension following intravitreal injections of 0.5 mg/0.05 ml ranibizumab
    Loukianou E.
    Brouzas D.
    Apostolopoulos M.
    International Ophthalmology, 2011, 31 (3) : 211 - 213
  • [30] OZURDEX® (dexamethasone intravitreal implant) 0.7 mg for Treating Inflammation in Macular Edema Following Retinal Vein Occlusion: A Case-Based Discussion
    Ip, Michael S.
    Bakri, Sophie J.
    Roth, Daniel
    Rachitskaya, Aleksandra
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 : 2 - +
12345